Amgen Inc.
Anti-erythropoietin antibodies
Last updated:
Abstract:
The present disclosure provides compositions and methods relating to antibodies that specifically bind to human erythropoietin. The disclosure provides nucleic acids encoding such antibodies and methods of making and using such antibodies.
Status:
Grant
Type:
Utility
Filling date:
4 Aug 2016
Issue date:
24 Dec 2019